BCBramsh Qamar Chandio

Bramsh Qamar Chandio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bramsh Qamar Chandio has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Eleftherios Garyfallidis

    Indiana University Bloomington, Bloomington, IN USA

    5 shared publications
  • Jaroslaw Harezlak

    Indiana University School of Public Health‐ Bloomington, Bloomington, IN USA

    5 shared publications
  • Neda Jahanshad

    Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, University of Southern California, Marina del Rey, CA USA

    5 shared publications
  • Yixue Feng

    Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA USA

    5 shared publications
  • Julio E. Villalon-Reina

    Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA

    3 shared publications
  • Paul M. Thompson

    Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, University of Southern California, Marina del Rey, CA USA

    3 shared publications

Latest Publications

  • Open Access

    Harmonized Tractometry Visualizes Alzheimer’s Disease Effects on the Brain’s White Matter Tract Microstructure

    by Bramsh Q Chandio, Julio E Villalon Reina, Talia M Nir, Sophia I Thomopoulos, Yixue Feng, Sebastian M Benavidez, Neda Jahanshad, Jaroslaw Harezlak, Eleftherios Garyfallidis, Paul M. Thompson

    Background: Diffusion MRI (dMRI) metrics of brain microstructure offer valuable insight into Alzheimer’s disease (AD) pathology; recent reports have identified dMRI metrics that (1) tightly link with CSF or PET measures of amyloid and tau burden; and (2) mediate the relationship between CSF markers of AD and delayed logical memory performance, commonly impaired in early AD [1,2].To better localize white matter tract disruption in AD, our BUndle ANalytic (BUAN) [3] tractometry pipeline allows principled use of statistical methods to map factors affecting microstructural metrics along the 3D length of the brain’s fiber tracts. Here, we extended BUAN to pool data from multiple scanning protocols/sites ‐ using a new harmonized tractometry approach, based on ComBat [4,5], a widely‐used harmonization method modeling variations in multi‐site datasets due to site‐ and scanner‐specific effects.Method: We illustrate the effects of integrating ComBat into our BUAN tractometry pipeline. Analyzing Alzheimer’s Disease Neuroimaging Initiative (ADNI3) [6] data, we examined the impact of mild cognitive impairment (MCI) and AD on 38 white matter tracts, comparing results with and without harmonization.We analyzed data from 730 ADNI3 participants, scanned with seven dMRI protocols. After data preprocessing with the ADNI3 protocol [7,8], BUAN extracted 38 bundles and created along‐tract bundle profiles for microstructural metrics: FA, MD, AD, and RD (see Figure 1 for full names). ComBat was applied to each point in bundle profiles to correct for scanner protocol effects and linear mixed models (LMM) were used to study the group differences in MCI and AD versus cognitively healthy controls (CN).Result: Harmonized BUAN maps reveal AD and MCI effects throughout specific tracts (e.g., the left cingulum and right arcuate fasciculus; Figure 1, bottom panel). ComBat harmonization enhanced the sensitivity to detect group differences compared to LMM without scanner correction. Adding data ‐ even from different scanner protocols ‐ boosted power (Figure 2f‐g).Conclusion: In this application of harmonization in neurodegenerative tractometry analysis, we integrated ComBat into BUAN tractometry to merge dMRI data from diverse scanning protocols and sites. Future research will examine various ComBat versions and deep‐learning approaches to track AD pathology effects on the brain’s neural circuitry.


  • Open Access

    Harmonized Tractometry Visualizes Alzheimer’s Disease Effects on the Brain’s White Matter Tract Microstructure

    by Bramsh Q Chandio, Julio E Villalon Reina, Talia M Nir, Sophia I Thomopoulos, Yixue Feng, Sebastian M Benavidez, Neda Jahanshad, Jaroslaw Harezlak, Eleftherios Garyfallidis, Paul M. Thompson

    Background: Diffusion MRI (dMRI) metrics of brain microstructure offer valuable insight into Alzheimer’s disease (AD) pathology; recent reports have identified dMRI metrics that (1) tightly link with CSF or PET measures of amyloid and tau burden; and (2) mediate the relationship between CSF markers of AD and delayed logical memory performance, commonly impaired in early AD [1,2]. To better localize white matter tract disruption in AD, our BUndle ANalytic (BUAN) [3] tractometry pipeline allows principled use of statistical methods to map factors affecting microstructural metrics along the 3D length of the brain’s fiber tracts. Here, we extended BUAN to pool data from multiple scanning protocols/sites ‐ using a new harmonized tractometry approach, based on ComBat [4,5], a widely‐used harmonization method modeling variations in multi‐site datasets due to site‐ and scanner‐specific effects.Method: We illustrate the effects of integrating ComBat into our BUAN tractometry pipeline. Analyzing Alzheimer’s Disease Neuroimaging Initiative (ADNI3) [6] data, we examined the impact of mild cognitive impairment (MCI) and AD on 38 white matter tracts, comparing results with and without harmonization. We analyzed data from 730 ADNI3 participants, scanned with seven dMRI protocols. After data preprocessing with the ADNI3 protocol [7,8], BUAN extracted 38 bundles and created along‐tract bundle profiles for microstructural metrics: FA, MD, AD, and RD (see Fig. 1 for full names). ComBat was applied to each point in bundle profiles to correct for scanner protocol effects and linear mixed models (LMM) were used to study the group differences in MCI and AD versus cognitively healthy controls (CN).Result: Harmonized BUAN maps reveal AD and MCI effects throughout specific tracts (e.g., the left cingulum and right arcuate fasciculus; Fig. 1, bottom panel). ComBat harmonization enhanced the sensitivity to detect group differences compared to LMM without scanner correction. Adding data ‐ even from different scanner protocols ‐ boosted power (Fig. 2f‐g).Conclusion: In this application of harmonization in neurodegenerative tractometry analysis, we integrated ComBat into BUAN tractometry to merge dMRI data from diverse scanning protocols and sites. Future research will examine various ComBat versions and deep‐learning approaches to track AD pathology effects on the brain’s neural circuitry.

  • Amyloid, Tau, and APOE in Alzheimer’s Disease: Impact on White Matter Tracts

    by Bramsh Qamar Chandio, Julio E. Villalon-Reina, Talia M. Nir, Sophia I. Thomopoulos, Yixue Feng, Sebastian Benavidez, Neda Jahanshad, Jaroslaw Harezlak, Eleftherios Garyfallidis, Paul M. Thompson, et al.

    Alzheimer's disease (AD) is characterized by cognitive decline and memory loss due to the abnormal accumulation of amyloid-beta (Aβ) plaques and tau tangles in the brain; its onset and progression also depend on genetic factors such as the apolipoprotein E (APOE) genotype. Understanding how these factors affect the brain's neural pathways is important for early diagnostics and interventions. Tractometry is an advanced technique for 3D quantitative assessment of white matter tracts, localizing microstructural abnormalities in diseased populations in vivo. In this work, we applied BUAN (Bundle Analytics) tractometry to 3D diffusion MRI data from 730 participants in ADNI3 (phase 3 of the Alzheimer's Disease Neuroimaging Initiative; age range: 55-95 years, 349M/381F, 214 with mild cognitive impairment, 69 with AD, and 447 cognitively healthy controls). Using along-tract statistical analysis, we assessed the localized impact of amyloid, tau, and APOE genetic variants on the brain's neural pathways. BUAN quantifies microstructural properties of white matter tracts, supporting along-tract statistical analyses that identify factors associated with brain microstructure. We visualize the 3D profile of white matter tract associations with tau and amyloid burden in Alzheimer's disease; strong associations near the cortex may support models of disease propagation along neural pathways. Relative to the neutral genotype, APOE ϵ3/ϵ3, carriers of the AD-risk conferring APOE ϵ4 genotype show microstructural abnormalities, while carriers of the protective ϵ2 genotype also show subtle differences. Of all the microstructural metrics, mean diffusivity (MD) generally shows the strongest associations with AD pathology, followed by axial diffusivity (AxD) and radial diffusivity (RD), while fractional anisotropy (FA) is typically the least sensitive metric. Along-tract microstructural metrics are sensitive to tau and amyloid accumulation, showing the potential of diffusion MRI to track AD pathology and map its impact on neural pathways.


  • Open Access

    Amyloid, Tau, and APOE in Alzheimer’s Disease: Impact on White Matter Tracts

    by Bramsh Qamar Chandio, Julio E. Villalon-Reina, Talia M. Nir, Sophia I. Thomopoulos, Yixue Feng, Sebastian Benavidez, Neda Jahanshad, Jaroslaw Harezlak, Eleftherios Garyfallidis, Paul M. Thompson, et al.

    Alzheimer’s disease (AD) is characterized by cognitive decline and memory loss due to the abnormal accumulation of amyloid-beta (A β ) plaques and tau tangles in the brain; its onset and progression also depend on genetic factors such as the apolipoprotein E (APOE) genotype. Understanding how these factors affect the brain’s neural pathways is important for early diagnostics and interventions. Tractometry is an advanced technique for 3D quantitative assessment of white matter tracts, localizing microstructural abnormalities in diseased populations in vivo . In this work, we applied BUAN (Bundle Analytics) tractometry to 3D diffusion MRI data from 730 participants in ADNI3 (phase 3 of the Alzheimer’s Disease Neuroimaging Initiative; age range: 55-95 years, 349M/381F, 214 with mild cognitive impairment, 69 with AD, and 447 cognitively healthy controls). Using along-tract statistical analysis, we assessed the localized impact of amyloid, tau, and APOE genetic variants on the brain’s neural pathways. BUAN quantifies microstructural properties of white matter tracts, supporting along-tract statistical analyses that identify factors associated with brain microstructure. We visualize the 3D profile of white matter tract associations with tau and amyloid burden in Alzheimer’s disease; strong associations near the cortex may support models of disease propagation along neural pathways. Relative to the neutral genotype, APOE ɛ 3/ ɛ 3, carriers of the AD-risk conferring APOE ɛ 4 genotype show microstructural abnormalities, while carriers of the protective ɛ 2 genotype also show subtle differences. Of all the microstructural metrics, mean diffusivity (MD) generally shows the strongest associations with AD pathology, followed by axial diffusivity (AxD) and radial diffusivity (RD), while fractional anisotropy (FA) is typically the least sensitive metric. Along-tract microstructural metrics are sensitive to tau and amyloid accumulation, showing the potential of diffusion MRI to track AD pathology and map its impact on neural pathways.


  • Open Access

    Bundle Analytics based Data Harmonization for Multi-Site Diffusion MRI Tractometry

    by Bramsh Qamar Chandio, Julio E. Villalon-Reina, Talia M. Nir, Sophia I. Thomopoulos, Yixue Feng, Sebastian Benavidez, Neda Jahanshad, Jaroslaw Harezlak, Eleftherios Garyfallidis, Paul M. Thompson

    The neural pathways of the living human brain can be tracked using diffusion MRI-based tractometry. Alongtract statistical analysis of microstructural metrics can reveal the effects of neurological and psychiatric diseases with 3D spatial precision. To maximize statistical power to detect disease effects and factors that influence them, data from multiple sites and scanners must often be combined, yet scanning protocols and hardware may vary widely. For simple scalar metrics, data harmonization methods - such as ComBat and its variants - allow modeling of disease effects on derived brain metrics, while adjusting for effects of scanning site or protocol. Here, we extend this method to pointwise segment analyses of 3D fiber bundles by integrating ComBat into the BUndle ANalytics (BUAN) tractometry pipeline. In a study of the effects of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) on 38 white matter tracts, we merge data from 7 different scanning protocols used in the Alzheimer’s Disease Neuroimaging Initiative, which vary in voxel size and angular resolution. By incorporating ComBat harmonization, we model site- and scanner-specific effects, ensuring the reliability and comparability of results by mitigating confounding variables. We also evaluate choices that arise in extending batch adjustment to tracts, such as the regions used to estimate the correction. We also compare the approach to the simpler approach of modeling the site as a random effect. To the best of our knowledge, this is one of the first applications to adapt harmonization to 3D tractometry.